10-(2-(2-Methoxyethoxy)ethyl)-10H-phenothiazine, 98% GC, 25g

4-Bromo-N-ethylbenzenesulfonamide, 95.0%, 1g

(R)-6-Methoxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 95.0%, 250mg

4-tert-Butylphthalic anhydride, 95.0%, 5g

3-Bromophenethyl alcohol, 98.0%, 10g

5-Bromo-4-chloro-3-indolyl beta-D-Glucuronide Sodium Salt [for Biochemical Research]>98.0%(HPLC)(T)10mg

2-Methylhex-5-yn-2-ol, 98%, 10g

Ethyl 2-allylamino-4-methyl-thiazole-5-carboxylate, 98.0%, 5g

ARCA Cap Analog, ≥98 %, 50 µl, envase de plástico.

N-ETHYL-3-FLUOROANILINE, 95.0%, 1g

Recipiente de cristalización ROTILABO® con pico, 20 ml, 40 mm, 10 Unidad(es)

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine, 95.0%, 1g

2-Phenylethanamine hydrochloride, 95.0%, 250g